We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Accelerated hepatocellular carcinoma development in mice expressing the Pim-3 transgene selectively in the liver.
- Authors
Wu, Y.; Wang, Y. Y.; Nakamoto, Y.; Li, Y.-Y.; Baba, T.; Kaneko, S.; Fujii, C.; Mukaida, N.
- Abstract
Pim-3, a proto-oncogene with serine/threonine kinase activity, was enhanced in hepatocellular carcinoma (HCC) tissues. To address the roles of Pim-3 in HCC development, we prepared transgenic mice that express human Pim-3 selectively in liver. The mice were born at a Mendelian ratio, were fertile and did not exhibit any apparent pathological changes in the liver until 1 year after birth. Pim-3-transgenic mouse-derived hepatocytes exhibited accelerated cell cycle progression. The administration of a potent hepatocarcinogen, diethylnitrosamine (DEN), induced accelerated proliferation of liver cells in Pim-3 transgenic mice in the early phase, compared with that observed for wild-type mice. Treatment with DEN induced lipid droplet accumulation with increased proliferating cell numbers 6 months after the treatment. Eventually, wild-type mice developed HCC with a frequency of 40% until 10 month after the treatment. Lipid accumulation was accelerated in Pim-3 transgenic mice with higher proliferating cell numbers, compared with that observed for wild-type mice. Pim-3 transgenic mice developed HCC with a higher incidence (80%) and a heavier burden, together with enhanced intratumoral CD31-positive vascular areas, compared with that observed for wild-type mice. These observations indicate that Pim-3 alone cannot cause, but can accelerate HCC development when induced by a hepatocarcinogen, such as DEN.
- Subjects
LIVER cancer; TRANSGENIC animals; APOPTOSIS; CELL cycle; LIVER cells; RODENTS
- Publication
Oncogene, 2010, Vol 29, Issue 15, p2228
- ISSN
0950-9232
- Publication type
Article
- DOI
10.1038/onc.2009.504